Nectar Health Sciences is a privately-owned cannabinoid isolation and extraction company. We are a team of experienced scientists and industry experts who are dedicated to commercializing our unique, patented cannabinoid isolation technology. Our research scientists have developed a novel, chemistry-based purification process that isolates cannabinoids to >99% purity.
We have entered the final stages of design and deployment of our proprietary system, developed to meet the growing global demand for plant-derived cannabinoid isolates. Our objective is to deliver industry-leading volumes of the highest quality isolate at the lowest cost.
CEO & Director
Paul brings over 25 years of experience from a varied business career in which he was involved in a wide array of pursuits including marketing institutional investment management services, mergers and acquisitions and international market expansion. Through this experience and his qualifications, (BSc, MBA, CFA) he has a sound and thorough understanding in the business practices required to keep the company focused on its critical path. Paul is committed to help uncover new specialized markets and to continuing to identify and develop the partnerships the company will rely on to commercialize its core technology.
Jay Van der Vlugt
Director of Compliance & Intellectual Property, Senior Biochemist
Jay brings seven years of experience in technology development with a number of biotechnology and applied chemistry start-ups. He holds a BSc. in biochemistry from the University of Victoria and is the Head of Laboratory at Nectar’s Cannabis Research and Analytical Testing facility. Jay specializes in cannabis and controlled substance regulatory compliance and plays a key role in directing the research efforts supporting Nectar’s growing Intellectual Property portfolio.